International scientific society · Founded 2026
SIRiiM International Society for Radiation Immunity and Immuno-Modulation

Home / Governance / Committees / Finance

Governance

Finance Advisory (Institute)

Finance Advisory helps develop budget strawmen for SIRiiM as an Institute program. All seats are VACANT pending internal interest, Board slate review, and Clay Hess / Institute Board clearance. Institute Accounting is the authority for money movement. Finance Advisory has no bank authority.

Mission and controls

  • Advise on meeting and program budgets with Institute Accounting.
  • Explore membership dues assumptions with Membership; live billing remains HOLD.
  • Research sponsorship possibilities internally; outside outreach remains HOLD.
  • Keep all treasury work on the Institute path. There is no separate society bank account, EIN, or unauthorized payment link.

Seats (VACANT)

Seat / workstream Status
FIN Chair (Finance / Treasury Liaison may be ex officio) VACANT
Meeting budget advisor VACANT (1)
Membership dues advisor VACANT (1)
Grants / sponsorship explore VACANT (1; outreach HOLD)

Planning target: 3–4 seats. Institute Accounting remains accountable for money movement and any future Anedot / nonprofit treasury path.

How bots work with seated people

Institute bots work with each seated person on ops, coordination, drafts, and tracking; humans retain scientific and governance judgment. The default is a committee-level bot liaison. Personal bots require a named person and Clay Hess clearance. No PHI. Outside outreach remains HOLD until Clay clears a named recipient and message.

Interest (internal)

Use the internal volunteer interest form: /governance/volunteer

Submit interest (internal) — no public application or seating claim is implied.

Parent and guardrails

SIRiiM — International Society for Radiation Immunity and Immuno-Modulation, no Oxford comma — is an Institute program of the CureRays Innovation & Education Institute (501(c)(3)). Parent site: curerays.org. Clinic (curerays.com) is not the parent brand. SIRiiM makes no PubMed or Scopus claims. Awards remain HOLD.